Baupost Group
13F Holdings and Portfolio Analysis
Seth Klarman 2016 Q1 13F holdings, quarterly changes, portfolio value trend and position weight distribution.
Baupost Group Overview
Baupost Group held 36 stocks in 2016 Q1, with total market value around $6.92B.
Baupost Group's top five holdings in 2016 Q1: EMC CORP/MA COMMON STOCK 19.96%, CHENIERE ENERGY INC 14.58%, VIASAT INC(VSAT) 12.24%, ANTERO RES CORP 7.72%, ALLERGAN PFD CONV SER A 6.66%.
- Portfolio Value
- $6.92B
- Current Holdings
- 36 stocks
- New / Increased
- 8 / 10
- Reduced / Exited
- 4 / 7
Current Holdings
| 1 | EMC CORP/MA COMMON STOCKCUSIP 268648102 | 1.38 | 19.96% | 51.85 +77.28% | $26.65 | - | $26.10 | +22.60 | 0.50 | +$0.03B+2.10% | Increased |
| 2 | CHENIERE ENERGY INCCUSIP 16411R208 | 1.01 | 14.58% | 29.84 +14.38% | $33.83 | - | $42.98 | +3.75 | 2.25 | -$0.27B-21.29% | Increased |
| 3 | VIASAT INCVSAT | 0.85 | 12.24% | 11.53 - | $73.48 | - | $71.14 | 0.00 | 3.00 | +$0.03B+3.28% | Held |
| 4 | ANTERO RES CORPCUSIP 03674X106 | 0.53 | 7.72% | 21.51 +12.20% | $24.87 | - | $13.71 | +2.34 | 1.75 | +$0.24B+81.38% | Increased |
| 5 | ALLERGAN PFD CONV SER ACUSIP G0177J108 | 0.46 | 6.66% | 1.72 | $268.03 | - | $268.03 | +1.72 | 0.25 | $0.00B0.00% | New |
| 6 | PBF ENERGY INCCUSIP 69318G106 | 0.35 | 5.10% | 10.64 -3.48% | $33.20 | - | $26.47 | -0.38 | 2.75 | +$0.07B+25.42% | Reduced |
| 7 | PayPal Holdings, Inc.PYPL | 0.27 | 3.94% | 7.06 -36.45% | $38.60 | $45.76 +18.54% | $31.14 | -4.05 | 0.75 | +$0.10B+46.96% | Reduced |
| 8 | INNOVIVA INCCUSIP 45781M101 | 0.25 | 3.60% | 19.82 | $12.59 | - | $12.59 | +19.82 | 0.25 | $0.00B0.00% | New |
| 9 | TWENTY FIRST CENTY FOX INC CL AFOXA | 0.21 | 3.10% | 7.70 +87.84% | $27.88 | - | $27.40 | +3.60 | 0.75 | +$0.00B+1.75% | Increased |
| 10 | TWENTY FIRST CENTY FOX INC CL BCUSIP 90130A200 | 0.21 | 2.96% | 7.28 +11.50% | $28.20 | - | $27.19 | +0.75 | 0.75 | +$0.01B+3.73% | Increased |
| 11 | OLIN CORPCUSIP 680665205 | 0.19 | 2.69% | 10.74 +53.42% | $17.37 | - | $17.00 | +3.74 | 0.75 | +$0.00B+2.15% | Increased |
| 12 | THERAVANCE BIOPHARMA INCCUSIP G8807B106 | 0.12 | 1.76% | 6.50 +1.26% | $18.80 | - | $30.88 | +0.08 | 2.00 | -$0.08B-39.12% | Increased |
| 13 | KERYX BIOPHARMACEUTICALS INCCUSIP 492515101 | 0.12 | 1.74% | 25.79 - | $4.67 | - | $14.16 | 0.00 | 2.25 | -$0.24B-67.03% | Held |
| 14 | VMWARE INCCUSIP 928563402 | 0.12 | 1.70% | 2.25 | $52.31 | - | $52.31 | +2.25 | 0.25 | $0.00B0.00% | New |
| 15 | VERITIV CORPCUSIP 923454102 | 0.11 | 1.64% | 3.04 +5.50% | $37.26 | - | $46.74 | +0.16 | 1.75 | -$0.03B-20.27% | Increased |
| 16 | ATARA BIOTHERAPEUTICS INCCUSIP 046513107 | 0.10 | 1.47% | 5.36 - | $19.03 | - | $31.84 | 0.00 | 1.50 | -$0.07B-40.23% | Held |
| 17 | FORWARD PHARMA A/SCUSIP 34986J105 | 0.09 | 1.32% | 5.37 - | $17.00 | - | $20.83 | 0.00 | 1.50 | -$0.02B-18.39% | Held |
| 18 | NOVAGOLD RES INCCUSIP 66987E206 | 0.08 | 1.09% | 15.00 -20.96% | $5.04 | - | $2.11 | -3.98 | 3.00 | +$0.04B+138.86% | Reduced |
| 19 | CHIPMOS TECH BERMUDA LTDCUSIP G2110R114 | 0.07 | 0.94% | 3.75 - | $17.38 | - | $18.79 | 0.00 | 3.00 | -$0.01B-7.53% | Held |
| 20 | KLX INCCUSIP 482539103 | 0.06 | 0.93% | 2.00 - | $32.14 | - | $36.60 | 0.00 | 1.25 | -$0.01B-12.19% | Held |
| 21 | SUNEDISON SEMICONDUCTOR LTDCUSIP Y8213L102 | 0.05 | 0.78% | 8.37 - | $6.48 | - | $20.87 | 0.00 | 2.00 | -$0.12B-68.96% | Held |
| 22 | AMERICAN INTL GROUP INCCUSIP 026874156 | 0.04 | 0.57% | 2.12 +68.82% | $18.70 | - | $15.63 | +0.87 | 3.00 | +$0.01B+19.66% | Increased |
| 23 | SILVER RUN ACQUISITION CORPCUSIP 82811P200 | 0.04 | 0.56% | 3.75 | $10.35 | - | $10.35 | +3.75 | 0.25 | $0.00B0.00% | New |
| 24 | THERAVANCE INC CV SUB NTCUSIP 88338TAB0可转换债券 | 0.04 | 0.55% | 48.23 - | $0.78 | - | $0.86 | 0.00 | 1.75 | -$0.00B-8.75% | Held |
| 25 | BIOTIE THERAPIES OYJCUSIP 09074D103 | 0.04 | 0.53% | 1.40 - | $26.39 | - | $13.42 | 0.00 | 1.00 | +$0.02B+96.69% | Held |
Showing 1-25 of 36
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.
Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.
Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.
Exited Holdings
Stocks no longer disclosed in the current 13F portfolio for 2016 Q1.
| 1 | THERAVANCE INCCUSIP 88338T104 | 19.82 | 2.75 | $38.32 | $10.54 | -$0.55B-72.49% |
| 2 | FRONTIER COMMUNICATIONS CORPCUSIP 35906A108 | 10.92 | 0.75 | $4.95 | $4.67 | -$0.00B-5.66% |
| 3 | OCWEN FINANCIAL CORP COMMON STOCKCUSIP 675746309 | 5.20 | 1.50 | $21.91 | $6.97 | -$0.08B-68.18% |
| 4 | FRONTIER COMMUNICATIONS CORP 11.125% MAND CV PFDCUSIP 35906A207 | 0.33 | 0.75 | $99.90 | $91.58 | -$0.00B-8.33% |
| 5 | KOSMOS ENERGY LTDCUSIP G5315B107 | 4.62 | 1.75 | $10.25 | $5.20 | -$0.02B-49.28% |
| 6 | Micron Technology, Inc.MU | 1.00 | 2.75 | $15.43 | $14.16 | -$0.00B-8.25% |
| 7 | SANCHEZ ENERGY CORP COMMON STOCKCUSIP 79970Y105 | 2.00 | 0.75 | $3.25 | $4.31 | +$0.00B+32.49% |
Showing 1-7 of 7
Exited holdings are stocks disclosed in the previous report period but no longer disclosed in the current 13F portfolio.
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis uses the same weighted cost-pool method as current holdings. Estimated exit price uses the current report period weighted report price when available, otherwise the previous report price; it does not represent the actual sale price.
Exit return shows estimated dollar return on top and percentage return below.
Portfolio Visuals
Track portfolio value, position weights and Top 10 history.